Research records indexed for Sermorelin
This page carries 12 of the 27 records that the literature query returned for Sermorelin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 15 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Sermorelin.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance pmid:41966639 | 2026 | Review | other | Not stated | Indexed as review. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Musculoskeletal System; Athletic Injuries; Peptides; Peptide Fragments; Athletic Performance. |
| Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions pmid:41490200 | 2026 | review-article, Review | other | Not stated | Indexed as review-article, review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptides; Wound Healing; Signal Transduction. |
| The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration pmid:42395176 | 2026 | review-article, Review | other | Not stated | Indexed as review-article, review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Peptides; Insulin-Like Growth Factor I; Self Administration; Growth Hormone-Releasing Hormone. |
| A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review pmid:41880199 | 2026 | Review | other | Not stated | Indexed as review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptides; Anabolic Agents; Doping In Sports; Performance-Enhancing Substances; Anabolic Androgenic Steroids. |
| Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry pmid:41138283 | 2026 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Chromatography, Liquid; Substance Abuse Detection; Nanotechnology; Doping In Sports; Mass Spectrometry. |
| Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples pmid:38197510 | 2024 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Body Fluids; Cattle; Swine; Insulin; Insulin-Like Growth Factor I. |
| Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis pmid:36787346 | 2023 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Methanol; Sermorelin; Solvents; Electrophoresis, Capillary; Growth Hormone-Releasing Hormone. |
| Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples pmid:37806509 | 2023 | Research Support, Non-U.S. Gov't | other | Not stated | Indexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from assigned MeSH headings do not state a study model. subject headings: Sermorelin; Chromatography, High Pressure Liquid; Tandem Mass Spectrometry; Solid Phase Extraction. |
| In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides pmid:37688464 | 2023 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Serum; Growth Substances; Peptides; Clinical Chemistry Tests; Blood Chemical Analysis. |
| An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS pmid:35298973 | 2022 | Journal Article | other | Not stated | Indexed as journal article. compound named in the abstract, not the title. study model from assigned MeSH headings do not state a study model. subject headings: Sermorelin; Antibodies; Ultrafiltration; Chromatography, Affinity; Substance Abuse Detection. |
| Advances in the detection of growth hormone releasing hormone synthetic analogs pmid:34665524 | 2021 | Validation Study | other | Not stated | Indexed as validation study. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Sermorelin; Peptide Fragments; Chromatography, Liquid; Substance Abuse Detection; Doping In Sports. |
| Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? pmid:18046908 | 2006 | Editorial | other | Not stated | Indexed as editorial. study model from MeSH "Humans" with no interventional publication type. subject headings: Metabolic Diseases; Sermorelin; Growth Hormone; Hormone Replacement Therapy; Age Of Onset. |
Where this page sits
Compound page: Sermorelin. Class: GHRH analogues.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 16132413, Sermorelin. PubChem, National Library of Medicine (2026). pubchem:16132413
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:sermorelin
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs (1999). pmid:18031173
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?. Clin Interv Aging (2006). pmid:18046908
- Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology (1985). pmid:2859987
- Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology (1985). pmid:2994998
- A potentially effective drug for patients with recurrent glioma: sermorelin. Ann Transl Med (2021). pmid:33842627
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.